Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

ALX40-4C blocks HIV infection

May 10, 1996

DaunoXome launched in U.S. for HIV-related KS

May 10, 1996

Ribozyme treatment of HIV-1-infected patients

May 10, 1996

Saquinavir combinations under clinical evaluation

May 10, 1996

DuPont Merck discloses HIV protease inhibitors

May 10, 1996

Academic investigators report potential anti-HIV agents

May 10, 1996

U-31355: potent HIV-1 RTase inhibitor

May 10, 1996

HIV protease inhibitors revealed by Warner-Lambert

May 3, 1996

UC-70: NNRTI from Uniroyal

May 3, 1996

Sankyo reveals HIV protease inhibitors

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...